Real-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous Hemodiafiltration

(1) Objectives: to describe the pharmacokinetic/pharmacodynamic (PK/PD) profile of continuous infusion (CI) meropenem in critical patients with documented Gram-negative infections undergoing continuous veno-venous hemodiafiltration (CVVHDF) and to assess the relationship with microbiological outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatti, Milo, Rinaldi, Matteo, Tonetti, Tommaso, Siniscalchi, Antonio, Viale, Pierluigi, Pea, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604776/
https://www.ncbi.nlm.nih.gov/pubmed/37887225
http://dx.doi.org/10.3390/antibiotics12101524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604776/
https://www.ncbi.nlm.nih.gov/pubmed/37887225
http://dx.doi.org/10.3390/antibiotics12101524

Ejemplares similares